Japanese firms Eisai and Allm have agreed terms for a capital and business alliance agreement related to ICT digital health solutions and regional medical treatment and care. 9 May 2019
The pharmaceutical industry is adopting artificial intelligence (AI) on numerous fronts, from discovery and clinical development to risk assessment and safety monitoring, regulatory, and manufacturing. 8 May 2019
As pivotal changes in healthcare and drug development gain traction, new analysis from management consultancy Arthur D Little (ADL) highlights that all sectors of the industry must evolve their business and operating models in the coming decade. 2 May 2019
At its annual general meeting in Frankfurt, Merck KGaA outlined plans to secure future growth, including ambitious goals in the contract manufacturing sector, and in digital technologies. 26 April 2019
South Korea CNS medicines specialist SK Biopharmaceuticals and twoXAR, a US artificial intelligence (AI)-driven biopharmaceutical company, today announced an agreement to discover and develop first-in-class therapeutics for non-small cell lung cancer (NSCLC). 18 April 2019
The Pan American Health Organization (PAHO) and non-profit PATH have published a report detailing the opportunities to improve vaccine programs through effective data use. 3 April 2019
US biotech major Celgene has become the latest drugmaker to team up with Exscientia, a privately-owned UK-based company that uses artificial intelligence (AI) in drug discovery. 21 March 2019
Japanese drugmaker Ono Pharmaceutical has signed a drug discovery research collaboration with twoXAR, a USA-based artificial intelligence (AI)-driven biopharmaceutical company, to jointly discover and develop novel, efficacious treatments to address unmet medical needs in a specific neurological disease. 19 March 2019
PureTech Health today announced that its independent affiliate Akili has entered into a strategic partnership with Japan’s Shionogi for the commercialization of two of Akili’s digital medicine product candidates. 7 March 2019
Adhera Therapeutics and Alyvant, yesterday announced a digital co-promotion agreement for Prestalia (perindopril arginine and amlodipine) therapy for the treatment of hypertension. 5 March 2019
Sanofi, UCB and leading US insurer BlueCross BlueShield are among the new strategic shareholders in Aetion, a tech company with a real-world analytics and evidence platform to engage in value-based care. 5 February 2019
Today, the first patients in the European Union can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country. 21 January 2019
Swiss pharma giant Novartis (NOVN: VX) is to work with the University of Oxford’s Big Data Institute (BDI) to improve drug research and development using artificial intelligence (AI). 18 January 2019
US Food and Drug Administration Commissioner Scott Gottlieb has provided an update on the agency’s new actions under the Digital Health Precertification (Pre-Cert) Program. 8 January 2019
Californian companies Gilead Sciences and Genesis Therapeutics have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets. 10 September 2024
ZipBio, a newly launched start-up based in Seattle, USA, is aiming to set a new standard in the development of biologics and gene therapies by utilizing generative AI technology. 9 September 2024
Otsuka Pharmaceuticals says that its subsidiaries Otsuka Precision Health, Inc. (OPH) and Click Therapeutics (Click) have launched Rejoyn (developed as CT-152). 19 August 2024
CytoReason’s $80 million venture round may not have been the biggest in July, but it is one of a growing number of investor bets on AI powered drug discovery this year. 7 August 2024
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) across the entire pharmacovigilance (PV) value chain. However, over the next two years, the industry expects this number to only marginally shift to just 51%. 17 June 2024
Privately-held company GAIA has had more than a front-row seat to observe the arrival of digital therapeutics and applications of AI in pharma over the past quarter century. 4 June 2024
The use of AI across all industries and sectors has been heralded as driving efficiency and accelerating innovation, with some experts even citing the technology as the biggest disruptor of our lifetime. 21 May 2024
At a cool $1 billion, the venture round secured by AI group Xaira ranks as the second-biggest raise in biotech history. In the drug discovery space, this financing is dwarfed only by Altos Lab’s $3 billion, amassed back in 2021. 14 May 2024
The world’s top 20 pharma companies spent $145 billion between them on R&D investments in 2022-23 - compared to the prior year’s $139 million - according to research from the professional services firm Deloitte. 29 April 2024